{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:10:58Z","timestamp":1792001458572,"version":"4.4.0"},"reference-count":102,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1111\/jcpt.12404","type":"journal-article","created":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T01:08:43Z","timestamp":1464743323000},"page":"371-382","source":"Crossref","is-referenced-by-count":126,"title":["Will peripherally restricted kappa-opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential?"],"prefix":"10.1155","volume":"41","author":[{"given":"A.","family":"Albert-Vartanian","sequence":"first","affiliation":[{"name":"School of Pharmacy; Temple University; Philadelphia PA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. R.","family":"Boyd","sequence":"additional","affiliation":[{"name":"School of Pharmacy; Temple University; Philadelphia PA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. L.","family":"Hall","sequence":"additional","affiliation":[{"name":"School of Pharmacy; Temple University; Philadelphia PA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. J.","family":"Morgado","sequence":"additional","affiliation":[{"name":"School of Pharmacy; Temple University; Philadelphia PA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Nguyen","sequence":"additional","affiliation":[{"name":"School of Pharmacy; Temple University; Philadelphia PA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. P. H.","family":"Nguyen","sequence":"additional","affiliation":[{"name":"School of Pharmacy; Temple University; Philadelphia PA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. P.","family":"Patel","sequence":"additional","affiliation":[{"name":"School of Pharmacy; Temple University; Philadelphia PA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. J.","family":"Russo","sequence":"additional","affiliation":[{"name":"School of Pharmacy; Temple University; Philadelphia PA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. J.","family":"Shao","sequence":"additional","affiliation":[{"name":"School of Pharmacy; Temple University; Philadelphia PA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. B.","family":"Raffa","sequence":"additional","affiliation":[{"name":"School of Pharmacy; Temple University; Philadelphia PA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,6,1]]},"reference":[{"key":"10.1111\/jcpt.12404-BIB0001|jcpt12404-cit-0001","unstructured":"IASP http:\/\/www.iasp-pain.org\/Taxonomy"},{"key":"10.1111\/jcpt.12404-BIB0002|jcpt12404-cit-0002","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.jpain.2010.07.002","article-title":"The prevalence of chronic pain in United States adults: results of an Internet-based survey","volume":"11","author":"Johannes","year":"2010","journal-title":"J Pain"},{"key":"10.1111\/jcpt.12404-BIB0003|jcpt12404-cit-0003","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1185\/03007995.2012.703132","article-title":"The prevalence of chronic pain with an analysis of countries with a Human Development Index less than 0.9: a systematic review without meta-analysis","volume":"28","author":"Elzahaf","year":"2012","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/jcpt.12404-BIB0004|jcpt12404-cit-0004","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/ACO.0000000000000216","article-title":"Emerging targets in treating pain","volume":"28","author":"Chang","year":"2015","journal-title":"Curr Opin Anaesthesiol"},{"issue":"1 Suppl","key":"10.1111\/jcpt.12404-BIB0005|jcpt12404-cit-0005","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/S0885-3924(02)00411-6","article-title":"The impact of pain management on quality of life","volume":"24","author":"Katz","year":"2002","journal-title":"J Pain Symptom Manage"},{"key":"10.1111\/jcpt.12404-BIB0006|jcpt12404-cit-0006","first-page":"1","article-title":"Illness perceptions are the main predictors of depression and anxiety symptoms in patients with chronic pain","volume":"11","author":"Costa","year":"2015","journal-title":"Psychol Health Med"},{"key":"10.1111\/jcpt.12404-BIB0007|jcpt12404-cit-0007","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/jama.280.2.147","article-title":"Persistent pain and well-being: a World Health Organization study in primary care","volume":"280","author":"Gureje","year":"1998","journal-title":"JAMA"},{"key":"10.1111\/jcpt.12404-BIB0008|jcpt12404-cit-0008","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jpain.2012.03.009","article-title":"The economic costs of pain in the United States","volume":"13","author":"Gaskin","year":"2012","journal-title":"J Pain"},{"key":"10.1111\/jcpt.12404-BIB0009|jcpt12404-cit-0009","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-0034-1395272","article-title":"Global fertility and population trends","volume":"33","author":"Bongaarts","year":"2015","journal-title":"Semin Reprod Med"},{"issue":"Suppl 5","key":"10.1111\/jcpt.12404-BIB0010|jcpt12404-cit-0010","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00003495-199600525-00004","article-title":"The mechanisms of action of NSAIDs in analgesia","volume":"52","author":"Cashman","year":"1996","journal-title":"Drugs"},{"key":"10.1111\/jcpt.12404-BIB0011|jcpt12404-cit-0011","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-2125.2004.02198.x","article-title":"Current approaches to prevent NSAID-induced gastropathy-COX selectivity and beyond","volume":"58","author":"Becker","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/jcpt.12404-BIB0012|jcpt12404-cit-0012","doi-asserted-by":"crossref","first-page":"536962","DOI":"10.1155\/2015\/536962","article-title":"NSAIDs and cardiovascular diseases: role of reactive oxygen species","volume":"2015","author":"Ghosh","year":"2015","journal-title":"Oxid Med Cell Longev"},{"key":"10.1111\/jcpt.12404-BIB0013|jcpt12404-cit-0013","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1365-2710.2009.01143.x","article-title":"What do we (not) know about how paracetamol (acetaminophen) works?","volume":"35","author":"Toussaint","year":"2010","journal-title":"J Clin Pharm Ther"},{"key":"10.1111\/jcpt.12404-BIB0014|jcpt12404-cit-0014","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1021\/acs.chemrestox.5b00373","article-title":"What are the potential sites of protein arylation by N-acetyl-p-benzoquinone imine (NAPQI)?","volume":"28","author":"Leeming","year":"2015","journal-title":"Chem Res Toxicol"},{"key":"10.1111\/jcpt.12404-BIB0015|jcpt12404-cit-0015","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/ALN.0b013e318238bba6","article-title":"Molecular mechanisms of opioid receptor-dependent signaling and behavior","volume":"115","author":"Al-Hasani","year":"2011","journal-title":"Anesthesiology"},{"key":"10.1111\/jcpt.12404-BIB0016|jcpt12404-cit-0016","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1037\/a0013628","article-title":"Opioids and the treatment of chronic pain: controversies, current status, and future directions","volume":"16","author":"Rosenblum","year":"2008","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1111\/jcpt.12404-BIB0017|jcpt12404-cit-0017","doi-asserted-by":"crossref","first-page":"129","DOI":"10.55782\/ane-2011-1829","article-title":"Opioid peptides in peripheral pain control","volume":"71","author":"Lesniak","year":"2011","journal-title":"Acta Neurobiol Exp (Wars)"},{"issue":"Suppl 10","key":"10.1111\/jcpt.12404-BIB0018|jcpt12404-cit-0018","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1097\/AJP.0b013e3181c49e3a","article-title":"Delta and kappa opioid receptors as suitable drug targets for pain","volume":"26","author":"Vanderah","year":"2010","journal-title":"Clin J Pain"},{"key":"10.1111\/jcpt.12404-BIB0019|jcpt12404-cit-0019","first-page":"1113","article-title":"Intracisternal nor-binaltorphimine distinguishes central and peripheral kappa-opioid antinociception in rhesus monkeys","volume":"291","author":"Ko","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/jcpt.12404-BIB0020|jcpt12404-cit-0020","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2174\/1381612043453036","article-title":"Peripherally restricted opioid agonists as novel analgesic agents","volume":"10","author":"DeHaven-Hudkins","year":"2004","journal-title":"Curr Pharm Des"},{"key":"10.1111\/jcpt.12404-BIB0021|jcpt12404-cit-0021","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/sj.bjp.0705763","article-title":"Peripheral kappa-opioid agonists for visceral pain","volume":"141","author":"Rivi\u00e8re","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1111\/jcpt.12404-BIB0022|jcpt12404-cit-0022","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1124\/jpet.104.065391","article-title":"FE200041 (D-Phe-D-Phe-D-Nle-D-Arg-NH2): a peripheral efficacious kappa opioid agonist with unprecedented selectivity","volume":"310","author":"Vanderah","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/jcpt.12404-BIB0023|jcpt12404-cit-0023","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.bmcl.2004.12.018","article-title":"Synthesis and evaluation of novel peripherally restricted kappa-opioid receptor agonists","volume":"15","author":"Kumar","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1111\/jcpt.12404-BIB0024|jcpt12404-cit-0024","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1208\/s12248-009-9105-4","article-title":"Peptide kappa opioid receptor ligands: potential for drug development","volume":"11","author":"Aldrich","year":"2009","journal-title":"AAPS J"},{"key":"10.1111\/jcpt.12404-BIB0025|jcpt12404-cit-0025","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00213-010-1819-6","article-title":"Kappa opioids and the modulation of pain","volume":"210","author":"Kivell","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1111\/jcpt.12404-BIB0026|jcpt12404-cit-0026","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ajgsup.2014.5","article-title":"Molecular physiology of enteric opioid receptors","volume":"2","author":"Galligan","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/jcpt.12404-BIB0027|jcpt12404-cit-0027","first-page":"567","article-title":"International Union of Pharmacology. XII. Classification of opioid receptors","volume":"48","author":"Dhawan","year":"1996","journal-title":"Pharmacol Rev"},{"key":"10.1111\/jcpt.12404-BIB0028|jcpt12404-cit-0028","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1146\/annurev.biochem.73.011303.073940","article-title":"Opioid receptors","volume":"73","author":"Waldhoer","year":"2004","journal-title":"Annu Rev Biochem"},{"key":"10.1111\/jcpt.12404-BIB0029|jcpt12404-cit-0029","doi-asserted-by":"crossref","first-page":"249","DOI":"10.36076\/ppj.2011\/14\/249","article-title":"Peripherally acting opioids and clinical implications for pain control","volume":"14","author":"Sehgal","year":"2011","journal-title":"Pain Physician"},{"key":"10.1111\/jcpt.12404-BIB0030|jcpt12404-cit-0030","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.1440-1681.1999.03049.x","article-title":"Opioid receptor signalling mechanisms","volume":"26","author":"Connor","year":"1999","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1111\/jcpt.12404-BIB0031|jcpt12404-cit-0031","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1146\/annurev.pharmtox.40.1.389","article-title":"Molecular mechanisms and regulation of opioid receptor signaling","volume":"40","author":"Law","year":"2000","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1111\/jcpt.12404-BIB0032|jcpt12404-cit-0032","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1185\/03007995.2010.545379","article-title":"Opioids: a two-faced Janus","volume":"27","author":"Ahlbeck","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/jcpt.12404-BIB0033|jcpt12404-cit-0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1568026043451618","article-title":"Opioid receptors and their ligands","volume":"4","author":"Janecka","year":"2004","journal-title":"Curr Top Med Chem"},{"key":"10.1111\/jcpt.12404-BIB0034|jcpt12404-cit-0034","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1126\/science.6120570","article-title":"Dynorphin is a specific endogenous ligand of the kappa opioid receptor","volume":"215","author":"Chavkin","year":"1982","journal-title":"Science"},{"key":"10.1111\/jcpt.12404-BIB0035|jcpt12404-cit-0035","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1073\/pnas.79.17.5435","article-title":"Isolation and amino acid sequence analysis of a 4,000-dalton dynorphin from porcine pituitary","volume":"79","author":"Fischli","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/jcpt.12404-BIB0036|jcpt12404-cit-0036","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/377532a0","article-title":"Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor","volume":"377","author":"Meunier","year":"1995","journal-title":"Nature"},{"key":"10.1111\/jcpt.12404-BIB0037|jcpt12404-cit-0037","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.npep.2011.03.002","article-title":"The role of nociceptin and dynorphin in chronic pain: implications of neuro-glial interaction","volume":"45","author":"Mika","year":"2011","journal-title":"Neuropeptides"},{"key":"10.1111\/jcpt.12404-BIB0038|jcpt12404-cit-0038","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0301-0082(98)00067-7","article-title":"Nociceptin\/orphanin FQ: role in nociceptive information processing","volume":"57","author":"Yamamoto","year":"1999","journal-title":"Prog Neurobiol"},{"key":"10.1111\/jcpt.12404-BIB0039|jcpt12404-cit-0039","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0196-9781(00)00236-9","article-title":"Effects of supraspinal orphanin FQ\/nociceptin","volume":"21","author":"Grisel","year":"2000","journal-title":"Peptides"},{"key":"10.1111\/jcpt.12404-BIB0040|jcpt12404-cit-0040","first-page":"381","article-title":"The molecular and behavioral pharmacology of the orphanin FQ\/nociceptin peptide and receptor family","volume":"53","author":"Mogil","year":"2001","journal-title":"Pharmacol Rev"},{"key":"10.1111\/jcpt.12404-BIB0041|jcpt12404-cit-0041","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/S0024-3205(02)01477-7","article-title":"Characterisation of the non-peptide nociceptin receptor agonist, Ro64-6198 in Chinese hamster ovary cells expressing recombinant human nociceptin receptors","volume":"70","author":"Hashiba","year":"2002","journal-title":"Life Sci"},{"key":"10.1111\/jcpt.12404-BIB0042|jcpt12404-cit-0042","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/258577a0","article-title":"Identification of two related pentapeptides from the brain with potent opiate agonist activity","volume":"258","author":"Hughes","year":"1975","journal-title":"Nature"},{"key":"10.1111\/jcpt.12404-BIB0043|jcpt12404-cit-0043","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/386499a0","article-title":"A potent and selective endogenous agonist for the mu-opiate receptor","volume":"386","author":"Zadina","year":"1997","journal-title":"Nature"},{"key":"10.1111\/jcpt.12404-BIB0044|jcpt12404-cit-0044","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/0166-2236(83)90010-3","article-title":"Multiple endogenous opioid peptides","volume":"6","author":"H\u00f6llt","year":"1983","journal-title":"Trends Neurosci"},{"key":"10.1111\/jcpt.12404-BIB0045|jcpt12404-cit-0045","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1006\/geno.1994.1117","article-title":"Localization of the kappa opioid receptor gene to human chromosome band 8q11.2","volume":"19","author":"Yasuda","year":"1994","journal-title":"Genomics"},{"key":"10.1111\/jcpt.12404-BIB0046|jcpt12404-cit-0046","doi-asserted-by":"crossref","first-page":"7006","DOI":"10.1073\/pnas.92.15.7006","article-title":"kappa-Opioid receptor in humans: cDNA and genomic cloning, chromosomal assignment, functional expression, pharmacology, and expression pattern in the central nervous system","volume":"92","author":"Simonin","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/jcpt.12404-BIB0047|jcpt12404-cit-0047","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1527-3458.2003.tb00248.x","article-title":"A review of the properties of spiradoline: a potent and selective kappa-opioid receptor agonist","volume":"9","author":"Wadenberg","year":"2003","journal-title":"CNS Drug Rev"},{"key":"10.1111\/jcpt.12404-BIB0048|jcpt12404-cit-0048","unstructured":"NCBI http:\/\/www.ncbi.nlm.nih.gov\/snp?LinkName=gene_snp&from_uid=4986"},{"key":"10.1111\/jcpt.12404-BIB0049|jcpt12404-cit-0049","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1744-8069-9-20","article-title":"Gender, variation in opioid receptor genes and sensitivity to experimental pain","volume":"9","author":"Sato","year":"2013","journal-title":"Mol Pain"},{"key":"10.1111\/jcpt.12404-BIB0050|jcpt12404-cit-0050","doi-asserted-by":"crossref","first-page":"11934","DOI":"10.1073\/pnas.182234399","article-title":"Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist","volume":"99","author":"Roth","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/jcpt.12404-BIB0051|jcpt12404-cit-0051","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/npp.2010.137","article-title":"The therapeutic potential of kappa-opioids for treatment of pain and addiction","volume":"36","author":"Chavkin","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1111\/jcpt.12404-BIB0052|jcpt12404-cit-0052","first-page":"190","article-title":"Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders","volume":"6","author":"Butelman","year":"2015","journal-title":"Front Pharmacol"},{"key":"10.1111\/jcpt.12404-BIB0053|jcpt12404-cit-0053","doi-asserted-by":"crossref","first-page":"12917","DOI":"10.1523\/JNEUROSCI.2444-15.2015","article-title":"Kappa opioid receptor-induced aversion requires p38 MAPK activation in VTA dopamine neurons","volume":"35","author":"Ehrich","year":"2015","journal-title":"J Neurosci"},{"key":"10.1111\/jcpt.12404-BIB0054|jcpt12404-cit-0054","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00213-010-1806-y","article-title":"Kinase cascades and ligand-directed signaling at the kappa opioid receptor","volume":"210","author":"Bruchas","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1111\/jcpt.12404-BIB0055|jcpt12404-cit-0055","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.2174\/138161212803582405","article-title":"Non-analgesic effects of opioids: peripheral opioid receptors as promising targets for future anti-pruritic therapies","volume":"18","author":"Reich","year":"2012","journal-title":"Curr Pharm Des"},{"key":"10.1111\/jcpt.12404-BIB0056|jcpt12404-cit-0056","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fphar.2013.00123","article-title":"Targeting pain and inflammation by peripherally acting opioids","volume":"4","author":"Stein","year":"2013","journal-title":"Front Pharmacol"},{"key":"10.1111\/jcpt.12404-BIB0057|jcpt12404-cit-0057","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.coph.2008.12.009","article-title":"Peripheral mechanisms of opioid analgesia","volume":"9","author":"Stein","year":"2009","journal-title":"Curr Opin Pharmacol"},{"key":"10.1111\/jcpt.12404-BIB0058|jcpt12404-cit-0058","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neulet.2012.07.018","article-title":"Effects of peripheral kappa opioid receptor activation on inflammatory mechanical hyperalgesia in male and female rats","volume":"524","author":"Auh","year":"2012","journal-title":"Neurosci Lett"},{"key":"10.1111\/jcpt.12404-BIB0059|jcpt12404-cit-0059","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1744-8069-8-10","article-title":"Stimulation of peripheral kappa opioid receptors inhibits inflammatory hyperalgesia via activation of the PI3Kgamma\/AKT\/nNOS\/NO signaling pathway","volume":"8","author":"Cunha","year":"2012","journal-title":"Mol Pain"},{"key":"10.1111\/jcpt.12404-BIB0060|jcpt12404-cit-0060","doi-asserted-by":"crossref","first-page":"5161","DOI":"10.1096\/fj.12-208678","article-title":"Pain inhibition by blocking leukocytic and neuronal opioid peptidases in peripheral inflamed tissue","volume":"26","author":"Schreiter","year":"2012","journal-title":"FASEB J"},{"issue":"2 Suppl","key":"10.1111\/jcpt.12404-BIB0061|jcpt12404-cit-0061","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.36076\/ppj.2008\/11\/S121","article-title":"Peripherally-acting opioids","volume":"11","author":"Smith","year":"2008","journal-title":"Pain Physician"},{"key":"10.1111\/jcpt.12404-BIB0062|jcpt12404-cit-0062","first-page":"1000","article-title":"Contribution of opioid receptors on primary afferent versus sympathetic neurons to peripheral opioid analgesia","volume":"286","author":"Zhou","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/jcpt.12404-BIB0063|jcpt12404-cit-0063","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1124\/mol.64.2.202","article-title":"Painful inflammation-induced increase in mu-opioid receptor binding and G-protein coupling in primary afferent neurons","volume":"64","author":"Z\u00f6llner","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1111\/jcpt.12404-BIB0064|jcpt12404-cit-0064","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1124\/mol.104.003806","article-title":"Transcriptional regulation of the human mu-opioid receptor gene by interleukin-6","volume":"66","author":"B\u00f6rner","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1111\/jcpt.12404-BIB0065|jcpt12404-cit-0065","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0165-5728(03)00213-3","article-title":"Different mechanisms of intrinsic pain inhibition in early and late inflammation","volume":"141","author":"Machelska","year":"2003","journal-title":"J Neuroimmunol"},{"key":"10.1111\/jcpt.12404-BIB0066|jcpt12404-cit-0066","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0090-6980(79)90104-7","article-title":"II - Prostaglandin hyperalgesia: the peripheral analgesic activity of morphine, enkephalins and opioid antagonists","volume":"18","author":"Ferreira","year":"1979","journal-title":"Prostaglandins"},{"key":"10.1111\/jcpt.12404-BIB0067|jcpt12404-cit-0067","first-page":"148","article-title":"Anti-inflammatory effects of opioids","volume":"521","author":"Walker","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.1111\/jcpt.12404-BIB0068|jcpt12404-cit-0068","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1527-3458.2005.tb00270.x","article-title":"Bremazocine: a kappa-opioid agonist with potent analgesic and other pharmacologic properties","volume":"11","author":"Dortch-Carnes","year":"2005","journal-title":"CNS Drug Rev"},{"key":"10.1111\/jcpt.12404-BIB0069|jcpt12404-cit-0069","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/0024-3205(82)90341-1","article-title":"U-50488H, a pure kappa receptor agonist with spinal analgesic loci in the mouse","volume":"31","author":"Piercey","year":"1982","journal-title":"Life Sci"},{"key":"10.1111\/jcpt.12404-BIB0070|jcpt12404-cit-0070","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0014-2999(02)02275-6","article-title":"The kappa-opioid agonist (+\/-)-bremazocine elicits peripheral antinociception by activation of the L-arginine\/nitric oxide\/cyclic GMP pathway","volume":"454","author":"Amarante","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/jcpt.12404-BIB0071|jcpt12404-cit-0071","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ejphar.2004.05.009","article-title":"Study of the involvement of K+ channels in the peripheral antinociception of the kappa-opioid receptor agonist bremazocine","volume":"494","author":"Amarante","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/jcpt.12404-BIB0072|jcpt12404-cit-0072","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0031-6865(99)00044-8","article-title":"Kappa opioid agonists as targets for pharmacotherapies in cocaine abuse","volume":"74","author":"Neumeyer","year":"2000","journal-title":"Pharm Acta Helv"},{"key":"10.1111\/jcpt.12404-BIB0073|jcpt12404-cit-0073","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1476-5381.1980.tb07041.x","article-title":"A classification of opiate receptors that mediate antinociception in animals","volume":"69","author":"Tyers","year":"1980","journal-title":"Br J Pharmacol"},{"key":"10.1111\/jcpt.12404-BIB0074|jcpt12404-cit-0074","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1476-5381.1990.tb12110.x","article-title":"CI-977, a novel and selective agonist for the kappa-opioid receptor","volume":"101","author":"Hunter","year":"1990","journal-title":"Br J Pharmacol"},{"key":"10.1111\/jcpt.12404-BIB0075|jcpt12404-cit-0075","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00002826-199619050-00009","article-title":"Analgesic efficacy of enadoline versus placebo or morphine in postsurgical pain","volume":"19","author":"Pande","year":"1996","journal-title":"Clin Neuropharmacol"},{"key":"10.1111\/jcpt.12404-BIB0076|jcpt12404-cit-0076","doi-asserted-by":"crossref","first-page":"S","DOI":"10.1016\/S0016-5085(12)63199-0","article-title":"The kappa-opioid receptor agonist asimadoline remains peripherally restricted at supra-therapeutic plasma exposures","volume":"142","author":"Hicks","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1111\/jcpt.12404-BIB0077|jcpt12404-cit-0077","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejphar.2008.01.011","article-title":"Novel D-amino acid tetrapeptides produce potent antinociception by selectively acting at peripheral kappa-opioid receptors","volume":"583","author":"Vanderah","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/jcpt.12404-BIB0078|jcpt12404-cit-0078","volume-title":"Preclinical profile of CR845: a novel, long-acting peripheral kappa opioid receptor agonist","author":"Gardell","year":"2008"},{"key":"10.1111\/jcpt.12404-BIB0079|jcpt12404-cit-0079","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0304-3959(02)00259-2","article-title":"Analgesia from a peripherally active kappa-opioid receptor agonist in patients with chronic pancreatitis","volume":"101","author":"Eisenach","year":"2003","journal-title":"Pain"},{"key":"10.1111\/jcpt.12404-BIB0080|jcpt12404-cit-0080","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1111\/j.1476-5381.1994.tb17142.x","article-title":"A pharmacological profile of the novel, peripherally-selective kappa-opioid receptor agonist, EMD 61753","volume":"113","author":"Barber","year":"1994","journal-title":"Br J Pharmacol"},{"key":"10.1111\/jcpt.12404-BIB0081|jcpt12404-cit-0081","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000122444","article-title":"Inhibition of ADH release in the rat by narcotic antagonists","volume":"19","author":"Miller","year":"1975","journal-title":"Neuroendocrinology"},{"key":"10.1111\/jcpt.12404-BIB0082|jcpt12404-cit-0082","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1476-5381.1986.tb11160.x","article-title":"On the mechanisms of kappa-opioid-induced diuresis","volume":"89","author":"Blackburn","year":"1986","journal-title":"Br J Pharmacol"},{"key":"10.1111\/jcpt.12404-BIB0083|jcpt12404-cit-0083","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","article-title":"Structure and function of the blood-brain barrier","volume":"37","author":"Abbott","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.1111\/jcpt.12404-BIB0084|jcpt12404-cit-0084","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1002\/j.1552-4604.1994.tb01991.x","article-title":"Diuretic effects, pharmacokinetics, and safety of a new centrally acting kappa-opioid agonist (CI-977) in humans","volume":"34","author":"Reece","year":"1994","journal-title":"J Clin Pharmacol"},{"key":"10.1111\/jcpt.12404-BIB0085|jcpt12404-cit-0085","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1055\/s-0028-1094592","article-title":"CNS effects of the antihistamines diphenhydramine and terfenadine (RMI 9918)","volume":"12","author":"Fink","year":"1979","journal-title":"Pharmakopsychiatr Neuropsychopharmakol"},{"key":"10.1111\/jcpt.12404-BIB0086|jcpt12404-cit-0086","first-page":"S189","article-title":"Long acting, selective, peripheral kappa agonists","volume":"6","author":"Wisniewski","year":"2000","journal-title":"J Peptide Sci"},{"key":"10.1111\/jcpt.12404-BIB0087|jcpt12404-cit-0087","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0304-3959(98)00062-1","article-title":"Effects of antihyperalgesic drugs on experimentally induced hyperalgesia in man","volume":"76","author":"Bickel","year":"1998","journal-title":"Pain"},{"key":"10.1111\/jcpt.12404-BIB0088|jcpt12404-cit-0088","volume-title":"Development of the novel, peripherally-selective kappa opioid agonist CR665 for the treatment of acute pain","author":"Menzaghi","year":"2008"},{"key":"10.1111\/jcpt.12404-BIB0089|jcpt12404-cit-0089","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1097\/00000542-200106000-00018","article-title":"Analgesic and antiinflammatory effects of two novel kappa-opioid peptides","volume":"94","author":"Binder","year":"2001","journal-title":"Anesthesiology"},{"key":"10.1111\/jcpt.12404-BIB0090|jcpt12404-cit-0090","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/ALN.0b013e3181af6356","article-title":"Analgesic efficacy of peripheral kappa-opioid receptor agonist CR665 compared to oxycodone in a multi-modal, multi-tissue experimental human pain model: selective effect on visceral pain","volume":"111","author":"Arendt-Nielsen","year":"2009","journal-title":"Anesthesiology"},{"key":"10.1111\/jcpt.12404-BIB0091|jcpt12404-cit-0091","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2982.2008.01202.x","article-title":"Effect of a kappa-opioid agonist, i.v. JNJ-38488502, on sensation of colonic distensions in healthy male volunteers","volume":"21","author":"Floyd","year":"2009","journal-title":"Neurogastroenterol Motil"},{"key":"10.1111\/jcpt.12404-BIB0092|jcpt12404-cit-0092","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2174\/1874104501307010016","article-title":"Development of a peptide-derived orally-active kappa-opioid receptor agonist targeting peripheral pain","volume":"7","author":"Hughes","year":"2013","journal-title":"Open Med Chem J"},{"key":"10.1111\/jcpt.12404-BIB0093|jcpt12404-cit-0093","volume-title":"Anti-inflammatory effects of the peripheral kappa opioid receptor agonist CR845: a novel approach for the treatment of inflammatory disease","author":"Spencer","year":"2010"},{"key":"10.1111\/jcpt.12404-BIB0094|jcpt12404-cit-0094","volume-title":"Safety, pharmacokinetic and pharmacodynamic profile of CR845, a novel peptidergic kappa opioid agonist in development for the treatment of acute pain and itch","author":"O'Connor","year":"2010"},{"key":"10.1111\/jcpt.12404-BIB0095|jcpt12404-cit-0095","unstructured":"Menzaghi F O'Connor SJ Labissiere G Gardell LR Spencer RH Chalmers DT Analgesic and morphine-sparing effects of the kappa opioid agonist CR845 after single IV administration in women undergoing pararoscopic-assisted hysterectomy Montr\u00e9al 2010"},{"key":"10.1111\/jcpt.12404-BIB0096|jcpt12404-cit-0096","unstructured":"Medve RA Menzaghi F Stauffer J Tiseo P Spencer RH Analgesic efficacy of the peripheral kappa opioid agonist CR845 in laparoscopic hysterectomy National Harbor, MD American Academy of Pain Medicine 31st Annual Meeting 2015"},{"key":"10.1111\/jcpt.12404-BIB0097|jcpt12404-cit-0097","volume-title":"Analgesic efficacy of the peripheral kappa opioid agonist CR845 in laparoscopic hysterectomy","author":"Stauffer","year":"2015"},{"key":"10.1111\/jcpt.12404-BIB0098|jcpt12404-cit-0098","doi-asserted-by":"crossref","DOI":"10.1016\/j.pmrj.2015.06.185","volume-title":"CR845, a peripheral kappa opioid receptor agonist, provides better pain relief with less nausea and vomiting than placebo in patients after bunionectomy","author":"Menzaghi","year":"2015"},{"key":"10.1111\/jcpt.12404-BIB0099|jcpt12404-cit-0099","unstructured":"Therapeutics C http:\/\/ir.caratherapeutics.com\/releasedetail.cfm?ReleaseID=946233"},{"key":"10.1111\/jcpt.12404-BIB0100|jcpt12404-cit-0100","volume-title":"CR845, a novel peripherally acting kappa opioid receptor agonist, has low abuse potential compared with pentazocine","author":"Stauffer","year":"2015"},{"key":"10.1111\/jcpt.12404-BIB0101|jcpt12404-cit-0101","doi-asserted-by":"crossref","unstructured":"Webster LR Menzaghi F Spencer RH CR845, a novel peripherally acting kappa opioid receptor agonist, has low abuse potential compared with pentazocine Palm Springs, CA American Pain Society 34th Annual Scientific Meeting 2015","DOI":"10.1016\/j.jpain.2015.01.340"},{"key":"10.1111\/jcpt.12404-BIB0102|jcpt12404-cit-0102","first-page":"1065","article-title":"Chronic morphine use does not induce peripheral tolerance in a rat model of inflammatory pain","volume":"118","author":"Z\u00f6llner","year":"2008","journal-title":"J Clin Invest"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12404","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12404","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jcpt.12404\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T03:49:51Z","timestamp":1718596191000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,1]]},"references-count":102,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,8]]}},"URL":"https:\/\/doi.org\/10.1111\/jcpt.12404","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6,1]]}}}